These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Surgery for lymph node metastases of medullary thyroid carcinoma: A review. Jin LX; Moley JF Cancer; 2016 Feb; 122(3):358-66. PubMed ID: 26539937 [TBL] [Abstract][Full Text] [Related]
24. The relevance of preoperative ultrasound cervical mapping in patients with thyroid cancer. Kocharyan D; Schwenter F; Bélair M; Nassif E Can J Surg; 2016 Apr; 59(2):113-7. PubMed ID: 27007092 [TBL] [Abstract][Full Text] [Related]
25. Risk and survival of patients with medullary thyroid cancer: National perspective. Al-Qurayshi Z; Khadra H; Chang K; Pagedar N; Randolph GW; Kandil E Oral Oncol; 2018 Aug; 83():59-63. PubMed ID: 30098780 [TBL] [Abstract][Full Text] [Related]
26. Sentinel node radioguided biopsy in surgical management of the medullary thyroid carcinoma A case report. Boni G; Mazzarri S; Grosso M; Manca G; Biricotti M; Ambrosini CE; Fregoli L; Puccini M; Caldarelli C; Spisni R Ann Ital Chir; 2014 Jan; 85(ePub):. PubMed ID: 24556598 [TBL] [Abstract][Full Text] [Related]
27. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. Scollo C; Baudin E; Travagli JP; Caillou B; Bellon N; Leboulleux S; Schlumberger M J Clin Endocrinol Metab; 2003 May; 88(5):2070-5. PubMed ID: 12727956 [TBL] [Abstract][Full Text] [Related]
28. Neck management in medullary thyroid carcinoma. Oskam IM; Hoebers F; Balm AJ; van Coevorden F; Bais EM; Hart AM; van den Brekel MW Eur J Surg Oncol; 2008 Jan; 34(1):71-6. PubMed ID: 17555910 [TBL] [Abstract][Full Text] [Related]
29. Clinico-pathologic and dynamic prognostic factors in sporadic and familial medullary thyroid carcinoma: an Israeli multi-center study. Twito O; Grozinsky-Glasberg S; Levy S; Bachar G; Gross DJ; Benbassat C; Rozental A; Hirsch D Eur J Endocrinol; 2019 Jul; 181(1):13-21. PubMed ID: 31048559 [TBL] [Abstract][Full Text] [Related]
30. Risk Factors for Lateral Lymph Node Metastases in Patients With Sporadic Medullary Thyroid Carcinoma. Wu X; Li B; Zheng C; Liu W; Hong T; He X Technol Cancer Res Treat; 2020; 19():1533033820962089. PubMed ID: 32964812 [TBL] [Abstract][Full Text] [Related]
31. Surgical management of medullary thyroid cancer: which guidelines should we follow? Bowen A; Mani N; Penney S; Loughran S; Yap B J Laryngol Otol; 2015 May; 129(5):478-83. PubMed ID: 25994382 [TBL] [Abstract][Full Text] [Related]
32. The importance of sentinel lymph node intraoperative frozen analysis for indication of lateral neck dissection in patients with medullary thyroid cancer. Kralik R; Takacsova E; Waczulikova I; Arciniegas M; Sabol M; Durdik S; Grigerova M Neoplasma; 2024 Aug; 71(4):387-391. PubMed ID: 39267540 [TBL] [Abstract][Full Text] [Related]
33. Expression of the potential cancer stem cell markers CD133 and CD44 in medullary thyroid carcinoma: A ten-year follow-up and prognostic analysis. Bi Y; Meng Y; Wu H; Cui Q; Luo Y; Xue X J Surg Oncol; 2016 Feb; 113(2):144-51. PubMed ID: 26799258 [TBL] [Abstract][Full Text] [Related]
34. A comparative study of the surgical outcomes between video-assisted and open lateral neck dissection for papillary thyroid carcinoma with lateral neck lymph node metastases. Zhang D; Xie L; He G; Fang L; Miao Y; Wang Z; Gao L Am J Otolaryngol; 2017; 38(2):115-120. PubMed ID: 28041636 [TBL] [Abstract][Full Text] [Related]
35. Role of prophylactic central neck dissection in clinically node-negative differentiated thyroid cancer: assessment of the risk of regional recurrence. Calò PG; Lombardi CP; Podda F; Sessa L; Santini L; Conzo G Updates Surg; 2017 Jun; 69(2):241-248. PubMed ID: 28409443 [TBL] [Abstract][Full Text] [Related]
36. Long-Term Outcomes of Lateral Neck Dissection in Patients with Recurrent or Persistent Well-Differentiated Thyroid Cancer. Chinn SB; Zafereo ME; Waguespack SG; Edeiken BS; Roberts DB; Clayman GL Thyroid; 2017 Oct; 27(10):1291-1299. PubMed ID: 28806882 [TBL] [Abstract][Full Text] [Related]
37. Long-Term Follow-up in Medullary Thyroid Carcinoma. Raue F; Frank-Raue K Recent Results Cancer Res; 2015; 204():207-25. PubMed ID: 26494391 [TBL] [Abstract][Full Text] [Related]
38. Poorly differentiated thyroid carcinoma presenting with gross extrathyroidal extension: 1986-2009 Memorial Sloan-Kettering Cancer Center experience. Ibrahimpasic T; Ghossein R; Carlson DL; Chernichenko N; Nixon I; Palmer FL; Lee NY; Shaha AR; Patel SG; Tuttle RM; Balm AJ; Shah JP; Ganly I Thyroid; 2013 Aug; 23(8):997-1002. PubMed ID: 23311700 [TBL] [Abstract][Full Text] [Related]
39. Papillary thyroid cancer: controversies in the management of neck metastasis. Davidson HC; Park BJ; Johnson JT Laryngoscope; 2008 Dec; 118(12):2161-5. PubMed ID: 19029855 [TBL] [Abstract][Full Text] [Related]
40. Elective neck dissection versus observation in the management of early tongue carcinoma with clinically node-negative neck: a retrospective study of 229 cases. Feng Z; Li JN; Li CZ; Guo CB J Craniomaxillofac Surg; 2014 Sep; 42(6):806-10. PubMed ID: 24529348 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]